These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15668751)

  • 21. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
    Lebwohl M; Christophers E; Langley R; Ortonne JP; Roberts J; Griffiths CE;
    Arch Dermatol; 2003 Jun; 139(6):719-27. PubMed ID: 12810502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of alefacept in the treatment of chronic plaque psoriasis.
    Gordon KB; Valentine J
    J Cutan Med Surg; 2004 Dec; 8 Suppl 2():3-9. PubMed ID: 15668749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical use.
    Korman NJ; Moul DK
    Semin Cutan Med Surg; 2005 Mar; 24(1):10-8. PubMed ID: 15900794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.
    Huang PH; Liao YH; Wei CC; Tseng YH; Ho JC; Tsai TF
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):923-30. PubMed ID: 18312328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of alefacept in the treatment of psoriasis.
    Wong VK; Lebwohl M
    Skin Therapy Lett; 2003 Sep; 8(6):1-2, 7. PubMed ID: 14610613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of alefacept in elderly patients and other special populations.
    Gottlieb AB; Boehncke WH; Darif M
    J Drugs Dermatol; 2005; 4(6):718-24. PubMed ID: 16302557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
    Ortonne JP; Prinz JC
    Eur J Dermatol; 2004; 14(1):41-5. PubMed ID: 14965795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
    van de Kerkhof P; Griffiths CE; Christophers E; Lebwohl M; Krueger GG
    Dermatology; 2005; 211(3):256-63. PubMed ID: 16205071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alefacept for the treatment of psoriasis and other dermatologic diseases.
    Strober BE; Menon K
    Dermatol Ther; 2007; 20(4):270-6. PubMed ID: 17970892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
    Ortonne JP; Khemis A; Koo JY; Choi J
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis.
    Perlmutter A; Cather J; Franks B; Jaracz E; Menter A
    J Am Acad Dermatol; 2008 Jan; 58(1):116-24. PubMed ID: 17997502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis.
    Roberts JL; Ortonne JP; Tan JK; Jaracz E; Frankel E;
    J Am Acad Dermatol; 2010 Jun; 62(6):968-78. PubMed ID: 20392521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis.
    Gribetz CH; Blum R; Brady C; Cohen S; Lebwohl M
    J Am Acad Dermatol; 2005 Jul; 53(1):73-5. PubMed ID: 15965424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alefacept in the treatment of psoriasis.
    Sugiyama H; McCormick TS; Cooper KD; Korman NJ
    Clin Dermatol; 2008; 26(5):503-8. PubMed ID: 18755368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alefacept treatment for chronic plaque psoriasis.
    Dunn LK; Feldman SR
    Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ; Gerritsen WJ; van Rens DW; Seyger MM; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
    Krueger GG; Gottlieb AB; Sterry W; Korman N; Van De Kerkhof P
    J Dermatolog Treat; 2008; 19(3):146-55. PubMed ID: 18569270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting T-cell subsets to achieve remission.
    Christophers E
    J Eur Acad Dermatol Venereol; 2003 Jul; 17 Suppl 2():6-11. PubMed ID: 12795769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis.
    Ortonne JP; Lebwohl M; Em Griffiths C;
    Eur J Dermatol; 2003; 13(2):117-23. PubMed ID: 12695125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alefacept therapy produces remission for patients with chronic plaque psoriasis.
    Krueger GG; Ellis CN
    Br J Dermatol; 2003 Apr; 148(4):784-8. PubMed ID: 12752139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.